As of 2026-04-05, the Relative Valuation of Crinetics Pharmaceuticals Inc (CRNX) is (91.54) USD. This relative valuation is based on P/E multiples. With the latest stock price at 37.23 USD, the upside of Crinetics Pharmaceuticals Inc based on Relative Valuation is -345.9%.
The range of the Relative Valuation is (83.99) - (95.37) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 18.9x - 22.7x | 20.4x |
| Forward P/E multiples | 18.0x - 21.5x | 20.8x |
| Fair Price | (83.99) - (95.37) | (91.54) |
| Upside | -325.6% - -356.2% | -345.9% |
| Date | P/E |
| 2026-03-30 | -7.71 |
| 2026-03-27 | -7.58 |
| 2026-03-26 | -8.17 |
| 2026-03-25 | -8.18 |
| 2026-03-24 | -7.73 |
| 2026-03-23 | -7.81 |
| 2026-03-20 | -8.00 |
| 2026-03-19 | -8.06 |
| 2026-03-18 | -8.11 |
| 2026-03-17 | -8.53 |
| 2026-03-16 | -8.39 |
| 2026-03-13 | -8.44 |
| 2026-03-12 | -8.22 |
| 2026-03-11 | -8.32 |
| 2026-03-10 | -8.40 |
| 2026-03-09 | -8.60 |
| 2026-03-06 | -8.60 |
| 2026-03-05 | -8.75 |
| 2026-03-04 | -8.89 |
| 2026-03-03 | -9.03 |
| 2026-03-02 | -9.15 |
| 2026-02-27 | -9.25 |
| 2026-02-26 | -9.84 |
| 2026-02-25 | -9.76 |
| 2026-02-24 | -10.02 |
| 2026-02-23 | -9.85 |
| 2026-02-20 | -9.78 |
| 2026-02-19 | -9.90 |
| 2026-02-18 | -9.78 |
| 2026-02-17 | -9.83 |
| 2026-02-13 | -9.61 |
| 2026-02-12 | -9.92 |
| 2026-02-11 | -10.71 |
| 2026-02-10 | -10.71 |
| 2026-02-09 | -10.35 |
| 2026-02-06 | -10.19 |
| 2026-02-05 | -10.08 |
| 2026-02-04 | -10.67 |
| 2026-02-03 | -11.24 |
| 2026-02-02 | -11.11 |
| 2026-01-30 | -11.24 |
| 2026-01-29 | -11.67 |
| 2026-01-28 | -11.55 |
| 2026-01-27 | -11.92 |
| 2026-01-26 | -11.82 |
| 2026-01-23 | -11.97 |
| 2026-01-22 | -12.37 |
| 2026-01-21 | -12.47 |
| 2026-01-20 | -12.53 |
| 2026-01-16 | -12.60 |